
OncoLens, a provider of tumor board and cancer treatment planning solutions, has secured $7.25 million in Series A funding. The investors included BIP Capital, Martin Ventures, and SeedToB Capital.
Source: Press Release
OncoLens, a provider of tumor board and cancer treatment planning solutions, has secured $7.25 million in Series A funding.
OncoLens, a provider of tumor board and cancer treatment planning solutions, has secured $7.25 million in Series A funding. The investors included BIP Capital, Martin Ventures, and SeedToB Capital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination